| __timestamp | BioCryst Pharmaceuticals, Inc. | Merck & Co., Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 7461000 | 11606000000 |
| Thursday, January 1, 2015 | 13047000 | 10313000000 |
| Friday, January 1, 2016 | 11253000 | 9762000000 |
| Sunday, January 1, 2017 | 13933000 | 9830000000 |
| Monday, January 1, 2018 | 29514000 | 10102000000 |
| Tuesday, January 1, 2019 | 37121000 | 10615000000 |
| Wednesday, January 1, 2020 | 67929000 | 8955000000 |
| Friday, January 1, 2021 | 118818000 | 9634000000 |
| Saturday, January 1, 2022 | 159371000 | 10042000000 |
| Sunday, January 1, 2023 | 213894000 | 10504000000 |
Cracking the code
In the competitive landscape of pharmaceuticals, understanding the efficiency of Selling, General, and Administrative (SG&A) expenses is crucial. Over the past decade, Merck & Co., Inc. and BioCryst Pharmaceuticals, Inc. have showcased contrasting trends in their SG&A expenditures.
Merck, a global leader, has consistently maintained high SG&A expenses, peaking at approximately $11 billion in 2014. Despite fluctuations, their expenses have remained relatively stable, reflecting a strategic investment in marketing and administration to support their expansive operations.
In contrast, BioCryst, a smaller player, has seen a dramatic increase in SG&A expenses, growing by over 2700% from 2014 to 2023. This surge indicates aggressive expansion efforts and increased market penetration.
These trends highlight the diverse strategies employed by pharmaceutical companies to balance growth and operational efficiency.
Who Optimizes SG&A Costs Better? Merck & Co., Inc. or Bristol-Myers Squibb Company
Merck & Co., Inc. vs BeiGene, Ltd.: SG&A Expense Trends
Breaking Down SG&A Expenses: Merck & Co., Inc. vs MorphoSys AG
SG&A Efficiency Analysis: Comparing Merck & Co., Inc. and Vericel Corporation
SG&A Efficiency Analysis: Comparing Merck & Co., Inc. and Galapagos NV
Comparing SG&A Expenses: Bio-Techne Corporation vs BioCryst Pharmaceuticals, Inc. Trends and Insights
Who Optimizes SG&A Costs Better? Madrigal Pharmaceuticals, Inc. or BioCryst Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Cytokinetics, Incorporated and BioCryst Pharmaceuticals, Inc.
Cost Management Insights: SG&A Expenses for Alpine Immune Sciences, Inc. and BioCryst Pharmaceuticals, Inc.
PTC Therapeutics, Inc. or BioCryst Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing Catalyst Pharmaceuticals, Inc. and BioCryst Pharmaceuticals, Inc.
Breaking Down SG&A Expenses: MannKind Corporation vs BioCryst Pharmaceuticals, Inc.